Table 1:
Clinicopathological Characteristics of Patients
| INLP (N=102) | AMP (N=30) | INMP (N=296) | P Value | |
|---|---|---|---|---|
| Average age (range) | 66 (42–85) | 65 (50–80) | (67) 40–86 | 0.544 |
| Male:Female | 80:22 | 25:5 | 239:57 | 0.822 |
| Time from diagnosis to cystectomy in days (95%CI) | 309 (237–380) | 207 (124– 289) | 227 (190–265) | 0.353 |
| ≥pT2 at radical cystectomy | 50 (49%)* | 25 (83%)* | 255 (86%) | 0.002 |
| pT4 | 6 (6%)*ϕ | 1 (3.33%)ϕ | 52 (17%)* | *0.007; ϕ0.92 |
| Lymph node involvement | 18/98 (18%) | 6/25 (24%) | 96/272 (35%) | 0.887 |
| Follow up time in months (range) | 54 (2–192) | 58 (14–133) | 43 (0–151) | NA |
| Died of disease | 30 (29%)* | 5 (16.67%)ϕ | 117 (40%)*ϕ | *0.002; ϕ0.016 |
| Reason for surgery | ||||
| Symptoms | 14 (13%) | 7 (23%) | NA | 0.327 |
| Failure intravesical therapy | 67 (66%) | 9 (30%) | NA | 0.001 |
| High-risk high-grade tumor | 11 (11%) | 5 (17%) | NA | 0.583 |
| Unresectable by TUR | 8 (8%) | 6 (20%) | NA | 0.117 |
| Imaging studies convincing of ≥T2 | 2 (2%) | 3 (10%) | NA | 0.138 |
NA: Not applicable.
*
Values used to calculate the P value.
ϕ
Values used to calculate the P value.